<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Trop. Dis</journal-id>
<journal-title>Frontiers in Tropical Diseases</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Trop. Dis</abbrev-journal-title>
<issn pub-type="epub">2673-7515</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fitd.2024.1517628</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Tropical Diseases</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Recent outbreak of viral infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sah</surname>
<given-names>Ranjit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/376894"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rodriguez-Morales</surname>
<given-names>Alfonso J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/627786"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>SR Sanjeevani Hospital</institution>, <addr-line>Siraha</addr-line>, <country>Nepal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth</institution>, <addr-line>Pune, Maharashtra</addr-line>, <country>India</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth</institution>, <addr-line>Pune, Maharashtra</addr-line>, <country>India</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Faculty of Health Sciences, Universidad Cient&#xed;fica del Sur</institution>, <addr-line>Lima</addr-line>, <country>Peru</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University</institution>, <addr-line>Beirut</addr-line>, <country>Lebanon</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Aroop Mohanty, All India Institute Of Medical Sciences Gorakhpur, India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Alfonso J. Rodriguez-Morales, <email xlink:href="mailto:arodriguezmo@cientifica.edu.pe">arodriguezmo@cientifica.edu.pe</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>5</volume>
<elocation-id>1517628</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Sah and Rodriguez-Morales</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Sah and Rodriguez-Morales</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/55797" ext-link-type="uri">Editorial on the Research Topic <article-title>Recent outbreak of viral infections</article-title>
</related-article>
<kwd-group>
<kwd>outbreak</kwd>
<kwd>viruses</kwd>
<kwd>viral infection</kwd>
<kwd>measles</kwd>
<kwd>COVID-19</kwd>
<kwd>influenza</kwd>
<kwd>pandemic</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="18"/>
<page-count count="4"/>
<word-count count="1124"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Emerging Tropical Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Over the last few years, multiple viral outbreaks have significantly affected multiple countries across the continents, regionally and globally (<xref ref-type="bibr" rid="B1">1</xref>). Its approach represents multiple challenges for the scientific and medical community (<xref ref-type="bibr" rid="B2">2</xref>). One of the primary issues of viral outbreaks is related to the rapid mutation and evolution of viruses, as seen with influenza and SARS-CoV-2 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>), making predicting their behaviour difficult (<xref ref-type="bibr" rid="B3">3</xref>). These genetic changes can lead to new strains that may be more virulent or resistant to treatments and vaccines, complicating public health efforts, as especially occurred with the variants of concern (VOC) or interests (VOI) of SARS-CoV-2 (<xref ref-type="bibr" rid="B4">4</xref>), from Alpha to Omicron (<xref ref-type="bibr" rid="B5">5</xref>), which has become the predominant VOC/VOI (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Another challenge is global interconnectedness, where the ease of international travel accelerates the spread of viruses (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>), making containment much harder. Outbreaks that begin locally can quickly become global pandemics, as demonstrated during the COVID-19 crisis (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>SARS-CoV-2/COVID-19. <bold>(A)</bold> Global epidemiology, 2020-2024, according to the World Health Organisation (<ext-link ext-link-type="uri" xlink:href="https://data.who.int/dashboards/covid19/cases?n=c">https://data.who.int/dashboards/covid19/cases?n=c</ext-link>). <bold>(B)</bold> Evolution of the variant of concern/interest Omicron sublineages, September 2023-September 2024 (<ext-link ext-link-type="uri" xlink:href="https://gisaid.org/hcov19-variants/">https://gisaid.org/hcov19-variants/</ext-link>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fitd-05-1517628-g001.tif"/>
</fig>
<p>In many regions, particularly in low- and middle-income countries (LMIC), weak healthcare infrastructure and inadequate surveillance systems delay detection and response. This hinders the timely identification of new viral threats and hampers effective containment. Misinformation fueled by social media (<xref ref-type="bibr" rid="B10">10</xref>), contributes to vaccine hesitancy and resistance to public health measures (<xref ref-type="bibr" rid="B11">11</xref>), exacerbating the impact of outbreaks. Environmental factors such as deforestation and climate change increase the risk of zoonotic diseases jumping from animals to humans (<xref ref-type="bibr" rid="B12">12</xref>), further complicating outbreak prediction. Lastly, geopolitical tensions often obstruct international collaboration, slowing the sharing of crucial data and coordinated responses vital for controlling viral outbreaks globally.</p>
<p>Therefore, this Research Topic was proposed. It aimed to collect manuscripts on recent progress and future approaches to emerging viral diseases that help promote the development of effective prevention and treatment measures for viral threats in different regions of the world. Five papers, four Original Articles and one Opinion, have been accepted for this Research Topic.</p>
<p>In the article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fitd.2024.1391195">Mohapatra et&#xa0;al.</ext-link>, it was observed that since mid-October 2023, China has observed a rise in respiratory illness among children, attributed to seasonal changes and post-COVID-19 immunity shifts. The increase in cases is linked to pathogens like influenza, RSV, and <italic>Mycoplasma pneumoniae</italic>, without signs of novel or unusual viruses. The World Health Organization (WHO) has asked China for more data, while China&#x2019;s health authorities have bolstered surveillance and enhanced healthcare measures to monitor this trend. Studies suggest COVID-19-related hygiene practices may have temporarily suppressed common respiratory infections, but their resurgence post-pandemic could strain healthcare systems, especially in dense populations. Experts recommend preventive measures like vaccines, timely diagnoses, and travel advisories for international travellers to curb respiratory infection spread (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>The study of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpubh.2024.1377785">Dulkadir and Gunduz</ext-link> explores using haematological parameters to differentiate COVID-19 from influenza in children. Researchers analysed blood samples from 231 children aged 1 month to 18 years with respiratory symptoms, including 130 COVID-19 cases and 101 influenza cases. Key findings indicate that age, eosinophil count, and monocyte count are significantly associated with COVID-19. An increase in these factors raised the risk of a COVID-19 diagnosis. The study used ROC analysis to assess diagnostic accuracy, showing that monocyte and eosinophil counts achieved high sensitivity and specificity for COVID-19. That suggests that these parameters could serve as practical, cost-effective tools for distinguishing COVID-19 from influenza in clinical settings.</p>
<p>Also, related to influenza, the original investigation of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpubh.2024.1399672">Yin et&#xa0;al.</ext-link> examines the impact of influenza on excess mortality across various diseases in China from 2012 to 2021. Using data on influenza cases, population demographics, and mortality records, the researchers applied a negative binomial regression model to assess influenza&#x2019;s influence on eight health conditions, finding that respiratory and circulatory diseases accounted for the most significant portion (58.5%) of influenza-related excess deaths. On average, China experienced 201,722 influenza-related excess deaths annually, with a rate of 14.53/100,000 people. Influenza A (H1N1) and B strains were most strongly linked to deaths from respiratory diseases, chronic obstructive pulmonary disease, and ischemic heart disease. Seasonal peaks were noted, especially in winter, highlighting the need for targeted health interventions. The findings suggest that enhanced influenza surveillance and early warning systems could improve prevention and control of influenza&#x2019;s impact on mortality, especially among vulnerable populations.</p>
<p>Although significantly reduced over time in multiple countries, recent setbacks due to lack of vaccination, migration and antivaccine movements have set the stage for the reemergence of measles in some countries (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>). In the study of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpubh.2024.1331798">Tefera et&#xa0;al.</ext-link>, the authors investigate a measles outbreak in Tocha District, Ethiopia, from March to April 2023. This unmatched case-control study identified risk factors for measles in the Dawuro Zone. Data were collected from 147 confirmed cases and 147 controls. Analysis revealed that the attack rate was notably high among children under five (104.59/10,000), with a case fatality rate of 2.72%. Key risk factors included poor ventilation (adjusted odds ratio [AOR]=3.54) and contact history with measles cases (AOR=2.53). Vaccination coverage was insufficient, with only 53.88% of children receiving the measles vaccine. That highlighted the need for improved vaccination campaigns and surveillance. Public health recommendations include enhanced vaccination coverage, better cold chain management, and community awareness campaigns to reduce measles transmission.</p>
<p>Finally, in the study of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fitd.2024.1383211">Ghurab et&#xa0;al.</ext-link>, authors the role of the gut microbiome in the modulation of metabolic health and how dietary interventions can influence this relationship. It emphasises the connection between gut bacteria composition, nutrient absorption, and metabolic disorders like obesity and diabetes. The findings suggest that personalised dietary strategies tailored to individual microbiome profiles could enhance metabolic function and reduce the risk of related diseases. The authors advocate further exploring microbiome-targeted diets as a promising approach to improve health outcomes and inform future nutritional guidelines. Overall, the study underscores the importance of understanding the gut microbiome&#x2019;s role in metabolism and its potential for guiding effective dietary interventions.</p>
<p>Overall, several studies covered in this Research Topic have shown that surveillance and research on viral threats should be enhanced. Spillover continues to be critical of this. The transmission of viruses from animals to humans is often due to environmental changes, increased human-wildlife interaction, or habitat destruction. This process plays a crucial role in emergent viral outbreaks, facilitating the spread of zoonotic diseases and highlighting the need to monitor wildlife health and human encroachment on ecosystems.</p>
</body>
<back>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>RS: Investigation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. AR-M: Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>AR-M declared to have been a speaker/consultant in the last years for the following industries: Sanofi Pasteur, Johson &amp; Johnson, Abbott, Takeda, Amgen, AstraZeneca, MSD, and Valneva.</p>
<p>The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohanty</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mehta</surname> <given-names>R</given-names>
</name>
<name>
<surname>Srivastava</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sah</surname> <given-names>R</given-names>
</name>
<name>
<surname>Satapathy</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Rwanda&#x2019;s first Marburg virus outbreak</article-title>. <source>J Travel Med</source>. (<year>2024</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jtm/taae139</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rodriguez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Srivastava</surname> <given-names>S</given-names>
</name>
<name>
<surname>Memish</surname> <given-names>ZA</given-names>
</name>
<name>
<surname>Zumla</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Public Health Challenges at the Upcoming Kumbh Mela 2025: Addressing the Mpox global public health emergency of international concern</article-title>. <source>Travel Med Infect Dis</source>. (<year>2024</year>) <volume>62</volume>:<fpage>102771</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2024.102771</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tiwari</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sircar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bhat</surname> <given-names>S</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>YS</given-names>
</name>
<etal/>
</person-group>. <article-title>Coronavirus disease 2019-COVID-19</article-title>. <source>Clin Microbiol Rev</source>. (<year>2020</year>) <volume>33</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00028-20</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguilar-Martinez</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Sandoval-Pe&#xf1;a</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Molina-Mora</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Tsukayama-Cisneros</surname> <given-names>P</given-names>
</name>
<name>
<surname>D&#xed;az-V&#xe9;lez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Aguilar-Gamboa</surname> <given-names>FR</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic and phylogenetic characterisation of SARS-CoV-2 genomes isolated in patients from Lambayeque region, Peru</article-title>. <source>Trop Med Infect Dis</source>. (<year>2024</year>) <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/tropicalmed9020046</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farahat</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Abdelaal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Umar</surname> <given-names>TP</given-names>
</name>
<name>
<surname>El-Sakka</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Benmelouka</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Albakri</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends</article-title>. <source>Infez Med</source>. (<year>2022</year>) <volume>30</volume>:<page-range>480&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.53854/liim-3004-2</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlagenhauf</surname> <given-names>P</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rodriguez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Gautret</surname> <given-names>P</given-names>
</name>
<name>
<surname>Grobusch</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Leder</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021</article-title>. <source>Travel Med Infect Dis</source>. (<year>2021</year>) <volume>40</volume>:<fpage>101996</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2021.101996</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escalera-Antezana</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Lizon-Ferrufino</surname> <given-names>NF</given-names>
</name>
<name>
<surname>Maldonado-Alanoca</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alarc&#xf3;n-De-la-Vega</surname> <given-names>G</given-names>
</name>
<name>
<surname>Alvarado-Arnez</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Balderrama-Saavedra</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain</article-title>. <source>Travel Med Infect Dis</source>. (<year>2020</year>) <volume>35</volume>:<fpage>101653</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101653</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ozaki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rodriguez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Tanimoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sah</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Limiting spread of COVID-19 from cruise ships: lessons to be learnt from Japan</article-title>. <source>QJM</source>. (<year>2020</year>) <volume>113</volume>:<page-range>309&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/qjmed/hcaa092</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poudel</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ishak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Perez-Fernandez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>E</given-names>
</name>
<name>
<surname>Le&#xf3;n-Figueroa</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Roman&#xed;</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts - What is known so far</article-title>? <source>Travel Med Infect Dis</source>. (<year>2022</year>) <volume>45</volume>:<fpage>102234</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2021.102234</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>OH</given-names>
</name>
</person-group>. <article-title>Public trust, misinformation and COVID-19 vaccination willingness in Latin America and the Caribbean: today&#x2019;s key challenges</article-title>. <source>Lancet Reg Health Am</source>. (<year>2021</year>) <volume>3</volume>:<fpage>100073</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lana.2021.100073</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangla</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zohra Makkia</surname> <given-names>FT</given-names>
</name>
<name>
<surname>Pathak</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sultana</surname> <given-names>N</given-names>
</name>
<name>
<surname>Koonisetty</surname> <given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>COVID-19 vaccine hesitancy and emerging variants: evidence from six countries</article-title>. <source>Behav Sci (Basel)</source>. (<year>2021</year>) <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/bs11110148</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonilla-Aldana</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Su&#xe1;rez</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Franco-Paredes</surname> <given-names>C</given-names>
</name>
<name>
<surname>Vilcarromero</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mattar</surname> <given-names>S</given-names>
</name>
<name>
<surname>G&#xf3;mez-Mar&#xed;n</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Brazil burning! What is the potential impact of the Amazon wildfires on vector-borne and zoonotic emerging diseases? - A statement from an international experts meeting</article-title>. <source>Travel Med Infect Dis</source>. (<year>2019</year>) <volume>31</volume>:<fpage>101474</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2019.101474</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz-Arocutipa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Saucedo-Chinchay</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mamas</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Vicent</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Influenza vaccine improves cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis</article-title>. <source>Travel Med Infect Dis</source>. (<year>2022</year>) <volume>47</volume>:<fpage>102311</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2022.102311</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dao</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Levasseur</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tall</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Hoang</surname> <given-names>VT</given-names>
</name>
<name>
<surname>Colson</surname> <given-names>P</given-names>
</name>
<name>
<surname>Caputo</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Epidemiology and genomic characterisation of travel-associated and locally-acquired influenza, Marseille, France</article-title>. <source>Travel Med Infect Dis</source>. (<year>2022</year>) <volume>45</volume>:<fpage>102236</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2021.102236</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Amaya Dimas</surname> <given-names>LDC</given-names>
</name>
</person-group>. <article-title>Influenza epidemic on a world cruise ship: A descriptive study</article-title>. <source>Travel Med Infect Dis</source>. (<year>2021</year>) <volume>44</volume>:<fpage>102176</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2021.102176</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siani</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries</article-title>. <source>Prev Med</source>. (<year>2019</year>) <volume>121</volume>:<fpage>99</fpage>&#x2013;<lpage>104</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ypmed.2019.02.011</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grobusch</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Rodriguez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Measles on the move</article-title>. <source>Travel Med Infect Dis</source>. (<year>2017</year>) <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>2</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2017.08.001</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Morales</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Su&#xe1;rez</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Risquez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Delgado-Noguera</surname> <given-names>L</given-names>
</name>
<name>
<surname>Paniz-Mondolfi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The current syndemic in Venezuela: Measles, malaria and more co-infections coupled with a breakdown of social and healthcare infrastructure. Quo vadis</article-title>? <source>Travel Med Infect Dis</source>. (<year>2019</year>) <volume>27</volume>:<fpage>5</fpage>&#x2013;<lpage>8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tmaid.2018.10.010</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>